Mariner
EBS icon

Mariner’s Emergent Biosolutions EBS Stock Holding History

Mariner’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$468K Buy
55,817
+14,722
+36% +$123K ﹤0.01% 2502
2026
Q1 		$341K Buy
41,095
+19,821
+93% +$205K ﹤0.01% 2756
2025
Q4 		$262K Buy
21,274
+3,307
+18% +$35.4K ﹤0.01% 2956
2025
Q3 		$158K Buy
17,967
+7,871
+78% +$61.2K ﹤0.01% 3253
2025
Q2 		$64.4K Sell
10,096
-1,040
-9% -$5.95K ﹤0.01% 3310
2025
Q1 		$54.1K Buy
11,136
+324
+3% +$2.68K ﹤0.01% 3303
2024
Q4 		$103K Sell
10,812
-200
-2% -$1.83K ﹤0.01% 3177
2024
Q3 		$90.1K Sell
11,012
-79
-0.7% -$718 ﹤0.01% 3109
2024
Q2 		$75.6K Buy
+11,091
New +$47.7K ﹤0.01% 3000

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Mariner's EBS Position: Q2 2026 in Review

Mariner increased its Emergent Biosolutions (EBS) stake by 36% in Q2 2026, buying an estimated $123K and bringing the position to 55,817 shares worth $468K. The position accounts for ﹤0.01% of the portfolio, ranked #2502.

Mariner first reported a position in EBS in Q2 2024 and has held it in 9 quarters since. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Mariner held 55,817 shares of Emergent Biosolutions worth $468K as of Q2 2026.
  • Mariner bought 14,722 Emergent Biosolutions shares in Q2 2026, an estimated $123K.
  • Emergent Biosolutions made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2502 holding.
  • Mariner first reported a position in Emergent Biosolutions in Q2 2024 and has held it in 9 quarters since.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.